Loading...

Intuitive Surgical, Inc.

0R29.LLSE
HealthcareMedical - Equipment & Services
$544.90
$-4.87(-0.89%)

Intuitive Surgical, Inc. (0R29.L) Stock Overview

Explore Intuitive Surgical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
17.24%
17.24%
Profit Growth
$6.93
29.18%
EPS Growth
$6.93
27.71%
Operating Margin
28.20%
32.95%
ROE
15.52%
29.18%
Dividend Yield
0.00%
Analyst Recommendations data is not available for 0R29.LAnalyst Recommendations details for 0R29.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

CEO

Dr. Gary S. Guthart Ph.D.

Employees

15,638

Headquarters

1020 Kifer Road, Sunnyvale, CA

Founded

2014

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.